Christopher M Lindblom - Net Worth and Insider Trading
Christopher M Lindblom Net Worth
The estimated net worth of Christopher M Lindblom is at least $0 dollars as of 2024-12-28. Christopher M Lindblom is the See Remarks of Infinity Pharmaceuticals Inc and owns about 2,158 shares of Infinity Pharmaceuticals Inc (INFIQ) stock worth over $0. Details can be seen in Christopher M Lindblom's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher M Lindblom has not made any transactions after 2012-11-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher M Lindblom
Christopher M Lindblom Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher M Lindblom owns 4 companies in total, including Infinity Pharmaceuticals Inc (INFIQ) , DNIB Unwind Inc (BINDQ) , and Millendo Therapeutics Inc (MLND) among others .
Click here to see the complete history of Christopher M Lindblom’s form 4 insider trades.
Insider Ownership Summary of Christopher M Lindblom
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INFIQ | Infinity Pharmaceuticals Inc | 2016-05-02 | Principal Accounting Officer |
BINDQ | DNIB Unwind Inc | 2015-03-07 | SVP & FINANCE & ADMINISTRATION |
MLND | Millendo Therapeutics Inc | 2013-06-07 | Vice President of Finance |
2013-06-07 | Vice President of Finance |
Christopher M Lindblom Latest Holdings Summary
Christopher M Lindblom currently owns a total of 1 stock. Christopher M Lindblom owns 2,158 shares of Infinity Pharmaceuticals Inc (INFIQ) as of November 26, 2012, with a value of $0.
Latest Holdings of Christopher M Lindblom
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
INFIQ | Infinity Pharmaceuticals Inc | 2012-11-26 | 2,158 | 0.00 | 0 |
Holding Weightings of Christopher M Lindblom
Christopher M Lindblom Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher M Lindblom has made a total of 0 transactions in Infinity Pharmaceuticals Inc (INFIQ) over the past 5 years. The most-recent trade in Infinity Pharmaceuticals Inc is the sale of 13,885 shares on November 26, 2012, which brought Christopher M Lindblom around $357,261.
Insider Trading History of Christopher M Lindblom
- 1
Christopher M Lindblom Trading Performance
Christopher M Lindblom Ownership Network
Christopher M Lindblom Owned Company Details
What does Infinity Pharmaceuticals Inc do?
Who are the key executives at Infinity Pharmaceuticals Inc?
Christopher M Lindblom is the Principal Accounting Officer of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .
Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary
Over the past 18 months, Christopher M Lindblom made no insider transaction in Infinity Pharmaceuticals Inc (INFIQ). Other recent insider transactions involving Infinity Pharmaceuticals Inc (INFIQ) include a net sale of 410,196 shares made by Adelene Q Perkins ,
In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.
Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Infinity Pharmaceuticals Inc Insider Transactions
Christopher M Lindblom Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher M Lindblom. You might contact Christopher M Lindblom via mailing address: C/o Infinity Pharmaceuticals, Inc., 780 Memorial Drive, Cambridge Ma 02139.